company logo

Assistant Controller in Boston, MA



$100K - $150K*




8 - 10 years

Job Description

Tafasitamab is an investigational, Fc-engineered therapeutic antibody targeting CD19 that is in development for the treatment of B cell malignancies. The focus of the development program is on relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL), a particularly aggressive form of lymphoma. Tafasitamab received a breakthrough therapy designation (BTD) from the FDA in 2017 based on preliminary data from the phase 2 L-MIND study, which is evaluating the safety and efficacy of Tafasitamab in combination with lenalidomide. MorphoSys published the final L-MIND data in May 2019, and filed the BLA for Tafasitamab with the FDA in December 2019 which got accepted on March 2nd, 2020 with a priority review status.

Job Summary & General Responsibilities

Key Accountabilities

  • Manages the timely preparation and review of monthly, quarterly and year-end financial statements
  • Leads relationship and activities with external audi
See More

Valid through: 2020-5-20

About MorphoSys AG

Total Jobs:
Average Pay:
Total value of jobs:
% Masters:
Learn More About MorphoSys AG
* Ladders Estimates